Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron

Deborah Stefanova1, Antoan Raychev2, Joao Arezes3

  • 1Molecular, Cellular, and Integrative Physiology Graduate Program and.

Blood
|May 4, 2017
PubMed

Insights

The hormone hepcidin protects against siderophilic bacteria by controlling non-transferrin-bound iron (NTBI). This finding suggests hepcidin analogs could treat specific bacterial infections.

Area of Science:

  • Immunology
  • Microbiology
  • Hematology

Background:

  • The iron-regulatory hormone hepcidin influences host defense during infection by sequestering iron.
  • The precise mechanisms and microbial targets of hepcidin-mediated immunity remain unclear.
  • Hepcidin's role in modulating iron availability for microbial pathogens requires further investigation.

Purpose of the Study:

  • To elucidate the mechanisms by which hepcidin and hypoferremia impact host defense against diverse microbial pathogens.
  • To determine the specific role of non-transferrin-bound iron (NTBI) in bacterial growth during infection.
  • To assess the potential therapeutic applications of hepcidin modulation for infectious diseases.

Main Methods:

  • Utilized mouse models of infection to study hepcidin's effects on host defense.
  • Investigated the impact of hepcidin and iron overload on the growth of various bacterial species, including siderophilic and nonsiderophilic pathogens.
  • Analyzed the role of non-transferrin-bound iron (NTBI) versus transferrin-bound iron in supporting bacterial replication.

Main Results:

  • Hepcidin conferred selective protection against siderophilic extracellular bacteria (Yersinia enterocolitica O9) by regulating NTBI levels.
  • Non-transferrin-bound iron significantly promoted the rapid growth of siderophilic bacteria in iron-overloaded conditions and human plasma.
  • Hepcidin modulation and iron loading did not broadly enhance intracellular infections (Mycobacterium tuberculosis) or affect nonsiderophilic extracellular bacteria (Y. enterocolitica O8, Staphylococcus aureus).

Conclusions:

  • Hepcidin's protective effect against certain bacterial infections is mediated through the control of non-transferrin-bound iron.
  • Non-transferrin-bound iron is a critical factor supporting the proliferation of siderophilic pathogens.
  • Hepcidin analogs represent a potential therapeutic strategy for treating infections caused by siderophilic bacteria.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.9K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
5.0K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.4K
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
622
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
2.1K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K